← SynDRA
ESCITALOPRAM
SynDRA canonical compound SYN0008318 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC6A4 |
|---|
| Mechanism of action | Selective serotonin reuptake inhibitor |
|---|
| Indication | depression | generalized anxiety disorder (GAD) |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SLC6A4
- ADRA1A
- CHRM1
- HRH1
- SLC6A2
- CYP2C19
- HTR2C
- NET
- SLC6A3
- Slc6a3
- Slc6a4
Mechanisms of action (all sources)
- Selective serotonin reuptake inhibitor
- SLC6A4 INHIBITOR
- Serotonin transporter inhibitor
- selective serotonin reuptake inhibitor (SSRI)
Drug classes
- Serotonin Uptake Inhibitors
- Membrane Transport Modulators
- Neurotransmitter Agents
- Neurotransmitter Uptake Inhibitors
- Selective Serotonin Reuptake Inhibitors
- Serotonin Agents
- Serotonin Reuptake Inhibitor
ATC classes
Cross-references
Synonyms
- (+)-(S)-Citalopram
- (+)-Citalopram
- (S)-Citalopram
- S-(+)-Citalopram
- seroplex
- escitalopram oxalate
- ESERTIA
- ESITOL
- (S)-(+)-CITALOPRAM
- (S)-CITALOPRAM
- Cipralex
- Escitalopram oxalate
- LU-26-054
- S-(+)-CITALOPRAM
- SEROPLEX
- Esertia
- Escitalopram [INN]
- Cipralex (TN)
- Escitalopram (INN)
- Esertia (TN)
- Lexapro (TN)
- S(+)-Citalopram
- (+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
- escitalopram (ep monograph)
- Esitol
- 4O4S742ANY
- Seroplex
- escitalopramum
- CHEBI:36791
- RefChem:5803
- DTXCID4028414
- N06AB10
- Escitalopram [INN:BAN]
- UNII-4O4S742ANY
- Escitalopram CRS
- PS28 - Escitalopram
Reported adverse events
- Suicide
- Serotonin syndrome
- Dizziness
- Fatigue
- Insomnia
- Seizure
- Parkinsonism
- Priapism
- Anorgasmia
- Constipation
- Somnolence
- Nausea
Look up ESCITALOPRAM in the interactive SynDRA portal →